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Buts 
Dans la littérature actuelle, peu d'études existent sur la relation entre la 
consommation d'alcool et le syndrome métabolique. Les quelques données disponibles sont 
contradictoires et très limitées chez les buveurs à haut risque. Quant au diabète, une 
association est connue entre la consommation à bas risque d'alcool et une prévalence 
diminuée de la maladie. Là encore, les données sur la consommation à haut risque sont très 
limitées. Par conséquent, notre but était d'étudier la relation entre la consommation 
d'alcool, le syndrome métabolique et le diabète dans la cohorte lausannoise (CoLaus), où la 
consommation moyenne d'alcool est nettement plus élevée que dans la plupart des études 
disponibles, notamment celles des États-Unis. 
Méthodes 
Nous avons analysé les données de 6172 hommes et femmes, âgés de 35 à 75 ans. La 
consommation d'alcool a été catégorisée en 0, 1-6, 7-13, 14-20, 21-27, 28-34 et ~35 boissons 
par semaine ou comme non-buveurs (0), buveurs à bas risque (1-13), à risque moyen à élevé 
(14-34) et à très haut risque (~35). Nous avons confirmé la consommation d'alcool par la y-
glutamyl transferase et la transferrine déficiente en hydrates de carbone (CDT). Après 
l'analyse des caractéristiques des groupes de consommateurs, nous avons utilisé des 
régressions multivariées pour évaluer la relation entre la consommation d'alcool, la 
prévalence du syndrome métabolique et du diabète ainsi que la résistance à l'insuline, 
déterminée par le modèle d'homéostasie de la résistance à l'insuline (HOMA-IR). Dans le 
modèle d'ajustement, nous avons inclus l'âge, le genre, le status tabagique, l'activité 
physique et le niveau de formation. Nous avons aussi comparé la relation du type d'alcool 
(vin, bière et spiritueux) avec le syndrome métabolique, le diabète et le HOMA-IR en testant 
l'hypothèse d'égalité de leurs coefficients de régression, après ajustement. 
Résultats 
Parmi les participants, 73% buvaient de l'alcool, 16% étant buveurs à risque moyen à 
élevé et 2% à risque très élevé. En analyse multivariée, la prévalence du syndrome 
métabolique et du diabète ainsi que le HOMA-IR moyen diminuaient avec la consommation 
d'alcool à bas risque et augmentaient avec la consommation à très haut risque, montrant 
une relation en U. La prévalence ajustée du syndrome métabolique était de 24% chez les 
non-buveurs, 19% chez les buveurs à bas risque (p<0.001 vs. non-buveurs), 20% chez ceux à 
risque moyen à élevé et 29% chez ceux à très haut risque (p=0.005 vs. bas risque). La 
prévalence ajustée du diabète était de 6.0% chez les non-buveurs, 3.6% chez les buveurs à 
bas risque (p<0.001 vs. non-buveurs), 3.8% chez ceux à risque moyen à élevé et 6.7% chez 
ceux à très haut risque (p=0.046 vs. bas risque). Le HOMA-IR moyen ajusté était de 2.47 chez 
les non-buveurs, 2.14 chez ceux à bas risque (p<0.001 vs. non-buveurs), 2.27 chez ceux à 
risque moyen à élevé et 2.53 chez ceux à très haut risque (p=0.04 vs. bas risque). Ces 
relations ne différaient pas selon les types de boissons. 
Conclusions 
La prévalence du syndrome métabolique, du diabète et le HOMA-IR baissent pour les 
faibles consommations d'alcool, mais augmentent à nouveau avec les plus fortes 
consommations, sans différence entre les types de boissons. 
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Aims To investigate the relationship of alcohol consumption with the metabolic syndrome and diabetes in a population-based 
study with high mean alcohol consumption. Few data exist on these conditions in high-risk drinkers, 
Methods In 6172 adults aged 35-75 years, alcohol consumption was categorized as 0, 1-6, 7-13, 14-20, 21-27, 28-34 and 
2 35 drinks/week or as non-drinkers (0), low-risk (1-13), medium-to-high-risk (14-34) and very-high-risk (2 35) drinkers, 
Alcohol consumption was objectively confirmed by biochemical tests, In multivariate analysis, we assessed the relationship of 
alcohol consumption with adjusted prevalence of the metabolic syndrome, diabetes and insulin resistance, determined with the 
homeostasis mode! assessment of insulin resistance (HOMA-IR), 
Results Seventy-three percent of participants consumed alcohol, 16% were medium-to-high-risk drinkers and 2 % very-high-
risk drinkers. In multivariate analysis, the prevalence of the metabolic syndrome, diabetes and mean HO MA-IR decreased with 
low-risk drinking and increased with high-risk drinking. Adjusted prevalence of the metabolic syndrome was 24% in non-
drinkers, 19% in low-risk (P < 0.001 vs. non-drinkers), 20% in medium-to-high-risk and 29% in very-high-risk drinkers 
(P = 0.005 vs. low-risk). Adjusted prevalence of diabetes was 6.0% in non-drinkers, 3.6% in low-risk (P < 0.001 vs. non-
drinkers), 3.8% inmedium-to-high-risk and 6.7% in very-high-risk drinkers (P = 0.046 vs. low-risk). AdjustedHOMA-IR was 
2.47 in non-drinkers, 2.14 in low-risk (P < 0.001 vs. non-drinkers), 2.27 in medium-to-high-risk and 2.53 in very-high-risk 
drinkers (P = 0.04 vs. low-risk). These relationships did not differ according to beverage types. 
Conclusions Alcohol has a U-shaped relationship with the metabolic syndrome, diabetes and HO MA-IR, without differences 
between beverage types. 
Diabet. Med. 27, 1241-1249 (2010) 
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The metabolic syndrome is a common condition characterized by 
a constellation of metabolic risk factors, namely elevated waist 
circumference, triglycerides, fasting glucose, blood pressure and 
reduced HDL cholesterol [1]. The metabolic syndrome is 
associated with an increased risk of cardiovascular disease and 
diabetes [1 ]. Only a few cross-sectional studies have investigated 
the relationship between alcohol consumption and the metabolic 
syndrome, with conflicting results [2-6]. Data are particularly 
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limited about the association between high-risk alcohol 
consumption and the metabolic syndrome [4,6], as highlighted 
by a recent meta-analysis [7]. Theoretically, the increase of blood 
pressure [8] and triglycerides [9] with alcohol use suggests that 
the metabolic syndrome might be more prevalent in high-risk 
drinkers. However, HDL cholesterol also increases with alcohol 
consumption [10]. Among low-risk drinkers, lower waist 
circumfere1ce, triglycerides and blood pressure levels were 
observed in some studies [2,11]. Finally, very few authors have 
compared the influence of different beverage types on the 
prevalence of the metabolic syndrome [2,5,12]. 
The relationship between alcohol consumption and Type 2 
diabetes was explored in several prospective studies, with meta-
analyses showing a 30% decreased risk of diabetes in low-risk 
1241 
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drinkers (13,14]. However, data are still limited and conflicting 
in high-risk drinkers and regarding possible differences according 
to beverage types (13,14]. Moreover, most epidemiological 
studies have found a reduced insulin resistance in low-risk 
drinkers, with limited and conflicting data in high-risk drinkers 
(15]. 
The aim of this study was to investigate the relationship of 
alcohol consumption with the prevalence of the metabolic 
syndrome and diabetes in a population-based study in 
Switzerland with high mean alcohol consumption and 
biochemical confirmation. 
Study population 
This cross-sectional study examined part1c1pants from a 
population-based sample including 6188 Caucasian 
community-dwelling men and women aged 35-75 years. The 
details of eligibility criteria have been described previously 
(16,17]. Briefly, participants were identified from a random 
sample of ail Caucasian age-eligible adults from the register of the 
city of Lausanne, Switzerland (117 161 inhabitants). The study 
included only Caucasian participants for genotyping purpose, as 
one of the aims of this study was to identify genetic determinants 
of cardiovaseular risk factors. No other exclusion criteria were 
applied. The institutional review board in Lausanne approved 
the protocol; ail participants gave written informed consent. 
They were interviewed and examined at the clinical centre in 
2003-2006. Venons blood samples were collected after 
overnight fasting. Insulin was measured by Pathway 
Diagnostics (Los Angeles, CA, USA). For this analysis, we 
excluded 16 participants with missing data for the metabolic 
syndrome, giving a final sample of 6172 participants. 
Alcohol consumption 
As previously described (18], participants reported whether they 
currently used alcohol and how many standard drinks of wine, 
beer and spirits they had consumed in the 7 days preceding 
assessment, using similar methods to previous studies (11,19]. A 
standard drink corresponds to approxima tel y 10-15 g of ethanol 
and was defined as a glass of wine, a bottle of beer or a shot of 
spirits (20]. Participants were categorized according to the 
number of standard drinks over the last week: 0, 1-6, 7-13, 
14-20, 21-27, 28-34 and 2 35, according to previous studies in 
this (18] and other populations (11,19]. Based on US and 
Australian guidelines (21,22] and previous definitions [20], an 
alternative 4-level classification was used: non-drinkers (0 
drink/week), low-risk drinkers (1-13 drinks/week), medium-
to-high-risk drinkers ( 14-34) and very-high-risk drinkers (2 35), 
the eut-off of very-high-risk drinking from the global burden of 
disease (23]. We used blood levels of y-glutamyl transferase 
(yGT) and carbohydrate-deficient transferrin as an objective 
confirmation of alcohol consumption. Carbohydrate-deficient 
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transferrin separation was obtained by capillary electrophoresis 
on a P/ ACE 5510 System (Beckman Coulter Instruments, Nyon, 
Switzerland). We did not exclude participants with high 
asialotransferrin but reporting no alcohol use, as the specificity 
of asialotransferrin is 92% for excessive drinking (18]. 
Metabolic syndrome 
We defined the metabolic syndrome according to the gender-
specific eut-offs of the updated Adult Treatment Panel-III criteria 
[1] by 2 3 of the following measurements: waist girth 2 8 8 cm in 
women or 2 102 cm in men; triglycerides 2 1. 7 mmol/l, use of 
fibrates or nicotinic acid; HDL cholesterol :0: 1.3 mmol/l in 
women or S: 1.03 mmol/l in men, use of fibrates or nicotinic 
acid; blood pressure 2 130/85 mmHg or use of anti-
hypertensive medication; fasting glucose 2 5.6 mmol/l, use of 
oral hypoglycaemic medication or insulin. As previously 
reported (18], triglycerides were measured by glycerol 
phosphate oxidase-p-aminophenazone. HDL cholesterol was 
assessed by enzymatic methods (cholesterol oxidase; Roche 
Diagnostics GmbH, Mannheim, Germany). Blood pressure was 
measured by trained field investigators three times on the left 
arm in the seated position after 2 10 min of rest, using an 
Omron HEM-907 automated oscillometric sphygmomanometer 
(Omron Matsusaka Company, Kyoto, Japan) with an 
appropriately sized cuff. The second and third results were 
averaged to reduce variability [2]. Fasting blood glucose was 
measured by glucose dehydrogenase. 
Diabetes 
We defined diabetes as fasting glucose 2 7 mmol/l, use of oral 
hypoglycaemic medication or insulin (24]. We performed 
additional sensitivity analyses excluding self-reported Type 1 
diabetes from this definition. 
lnsulin resistance 
We evaluated insulin resistance using the homeostasis mode! 
assessment of insulin resistance (HOMA-IR), defined as fasting 
insulin (pIU/ml) x fasting glucose (mmol/l)/22.5 (25]. This 
index is proportional to insulin resistance. A score of 1 
corresponds to the insulin resistance of a persan < 35 years old 
with normal weight (15]. The HOMA-IR has been validated in 
normoglycaemic subjects against insulin sensitivity measured 
directly by the euglycaemic-hyperinsulinemic clamp technique 
and has been widely used in epidemiological studies (25]. 
Covariates 
The smoking status was categorized as never, former or current 
smoker. Physical activity was assessed by questions on walking 
and other types of exercise. The socio-economic status was 
estimated using the education level, a validated proxy measure in 
Switzerland (18]. Cardiovaseular disease was defined as self-
© 2010 The Authors. 
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reported coronary heart disease, angina pectoris, myocardial 
infarction, coronary catheterization, coronary bypass, stroke or 
peripheral arterial disease. Weight and height were measured 
using Seca scale and height gauge (Seca, Reinach, Switzerland). 
Statistical analysis 
We conducted statistical analyses using Stata 10.1 (Stata Corp., 
College Station, TX, USA). First, we assessed bivariate 
relationships between categories of alcohol consumption and 
the metabolic syndrome, diabetes and other metabolic variables. 
Because of U-shaped relationships between alcohol use and the 
prevalence of the metabolic syndrome and diabetes, we also 
compared non-drinkers with low-risk drinkers, low-risk drinkers 
with very-high-risk drinkers and non-drinkers with very-high-
risk drinkers. We performed multivariate analyses to assess 
relations between alcohol and the metabolic syndrome, diabetes 
and HOMA-IR, adjusting for potential confounders. For these 
analyses, we used logistic regression for the prevalence of the 
metabolic syndrome and diabetes or linear regression for 
HOMA-IR [18]. Odds ratios were transformed to adjusted 
prevalence. Similar to previous studies [2 ], our adjustment mode! 
included age, gender, smoking status, physical activity and 
education level. As previously carried out [2], we did not include 
BMI in this mode!, because BMI was highly correlated with waist 
circumference (r = 0.84, P < 0.001), which is a criterion of the 
metabolic syndrome. Furthermore, obesity may be a mediating 
factor of the effect of alcohol consumption on diabetes [26]. 
However, we performed a sensitivity analysis with further 
adjustment for BMI. We used similar models for other variables. 
Finally, we assessed the effects of the type of alcoholic beverage 
on the metabolic syndrome, diabetes and HOMA-IR. For this 
analysis, we used three variables corresponding to the 
consumption of wine, beer and spirits in drinks/week. We 
introduced them in a multivariate mode! testing the hypothesis of 
the equality of the different regression coefficients for each 
beverage type, as described previously (18]. As this method 
compares linear fonctions, we included only drinkers of 
è'. 7 drinks/week to focus on the linear part of our results (18]. 
In this analysis, the adjustment mode! included the same above-
mentioned confounders and the number of drinks of each 
beverage type. 
Baseline characteristics of the study population (Table 1) 
Seventy-three per cent of participants had consumed alcohol in 
the last week, 55% were low-risk drinkers, 16% medium-to-
high-risk drinkers and 2 % very-high-risk drinkers. The gender 
proportions differed across drinking levels, with a minority of 
women in the upper categories. High levels of alcohol 
consumption were significantly associated with older age, male 
gender, current smoking, increasing y-glutamyl transferase and 
carbohydrate-deficient transferrin levels. Low-risk drinkers were 
© 2010 The Authors. 
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significantly Jess physically active and more educated than non-
drinkers and medium-to-high-risk drinkers (both P < 0.001). 
Wine was the most frequent beverage, but its relative 
consumption tended to decrease with increasing drinking 
levels, in favour of beer. 
Metabolic variables (Table 2) 
In multivariate analysis, high levels of alcohol consumption were 
significantly associated with increased triglycerides, HDL 
cholesterol, blood pressure, fasting glucose and number of 
metabolic criteria. Low-risk drinkers showed significantly 
reduced waist circumference, triglycerides, blood pressure, 
fasting glucose, fasting insulin and number of metabolic criteria 
compared with non-drinkers and very-high-risk drinkers. BMI 
and obesity were significantly reduced in low-risk drinkers 
compared with non-drinkers only. A similar result was found 
about the number of metabolic criteria restricted to participants 
with the metabolic syndrome (data not shown). Fasting blood 
glucose was significantly reduced in low-risk drinkers and then 
increased with high-risk alcohol consumption. After exclusion of 
241 participants under hypoglycaemic medication, glucose was 
similar between non-drinkers and low-risk drinkers, and then 
linearly increased with high-risk alcohol consumption. 
Relationships of alcohol use with high triglycerides, low HDL 
cholesterol and high blood pressure were not altered after 
excluding 49 participants under fibrates or nicotinic acid, or 
1094 participants under anti-hypertensive medications. Overall, 
the adjustment accentuated the favourable metabolic profile of 
low-risk drinkers and attenuated the more harmful profile at 
higher levels of alcohol consumption (see also Supporting 
Information, Table Sl). 
Metabolic syndrome, diabetes and HOMA-IR (Table 3) 
ln unadjusted analysis, the relationships of alcohol consumption 
with the prevalence of the metabolic syndrome or diabetes and 
the mean HOMA-IR followed J-shaped curves. The prevalence 
of the metabolic syndrome and diabetes were approximately 
twice higher in very-high-risk drinkers than in non-drinkers. 
After adjustment, low-risk drinkers had a significantly lower 
prevalence of the metabolic syndrome or diabetes and mean 
HOMA-IR compared with non-drinkers and very-high-risk 
drinkers. The adjusted prevalence rates in very-high-risk 
drinkers were higher than in non-drinkers, but not statistically 
different. Thus, the adjustment mode! transformed the J-shaped 
relationships into U-shaped ones (Fig. 1). Gender, smoking 
status and age were the most influential confounding factors in 
this model. The shape of these relationships did not differ by 
-gender (P for interaction: metabolic syndrome 0.55, diabetes 
0.52, HOMA-IR 0.61) and in gender-specific analyses (data not 
shown). Results were subject to more uncertainty for very-high-
risk drinking women, because of the limited sample (n = 13). In 
this small group, no case of diabetes was detected, although with 
similar adjusted prevalence of the metabolic syndrome (19%) to 
1243 
Characteristics of participants accorcling to alcohol conswnption in drinks during the last 7 days 
Non-drinkers Low risk Medium to high risk Very high 
Ali participants 0 1-6 7-13 14-20 21-27 28-34 2 35 P-value'" P for trendt 
Number of participants 6172 1670 (27%) 2181 (35%) 1202 (19%) 613 (10%) 264 (4%) 116 (2%) 126 (2%) 
Age (years) 53.1 ± 10.8 52.7 ± 10.9 52.5 ± 10.7 53.5 ± 10.8 54.5 ± 10.8 54.0 ± 10.0 54.2 ± 10.2 54.4 ± 10.8 < 0.001 0.01 
Women 3244 (53%) 1206 (72%) 1302 (60%) 504 (42%) 157 (26%) 49 (19%) 13 (11%) 13 (10%) < 0.001 < 0.001 
Smoking status < 0.001 
Never 2474 (40%) 877 (53%) 937 (43%) 402 (33%) 165 (27%) 54 (21 %) 18 (16%) 21 (17%) 
Former 2032 (33%) 427 (26%) 743 (34%) 454 (38%) 230 (38%) 90 (34%) 46 (40%) 42 (34%) 
Current 1665 (27%) 365 (22%) 501 (23%) 346 (29%) 218 (36%) 120 (45%) 52 (45%) 63 (50%) 
Physical activiryt (min/week) 228 ± 243 245 ± 256 206 ± 190 225 ± 248 245 ± 287 249 ± 317 256 ± 353 237 ± 249 < 0.001 0.23 
Education level (years) 13.0 ± 4.3 12.0 ± 4.3 13.5 ± 4.2 13.7 ± 4.0 12.9 ± 4.5 12.8 ± 4.0 13.6 ± 4.9 12.8 ± 4.2 < 0.001 0.28 
Cardiovascular clisease 429 (7%) 116 (7%) 139 (6%) 73 (6%) 52 (8%) 24 (9%) 16 (14%) 9 (7%) 0.02 0.07 
Diabetes in first-degree relatives 1363 (22%) 398 (24%) 497 (23%) 240 (20%) 119 (20%) 63 (24%) 24 (21 %) 22 (17%) 0.06 0.16 
Percentage of beverage types 
Wine 77 ± 31 80 ± 33 77 ± 28 76 ± 28 68 ± 28 68 ± 28 62 ± 29 < 0.001 < 0.001 
Beer 16 ± 26 13 ± 28 15 ±23 18 ± 25 23 ± 27 25 ± 27 29 ± 28 < 0.001 < 0.001 
Spirits 7 ± 19 7 ± 21 8 ± 18 6 ± 14 10 ± 16 7 ± 13 8 ± 17 0.21 0.46 
Laboratory data§ 
yGTiJ (U/l) 24 (23-24) 20 (19-21) 21 (20-21) 25 (24-26) 32 (30-34) 38 (35-42) 50 (43-59) 63 (55-72) < 0.001 < 0.001 
High CDT*'' 2 1.63% 366 (6%) 16 (1%) 32 (2%) 70 (6%) 87 (15%) 76 (30%) 32 (28%) 53 (46%) < 0.001 < 0.001 
High asialotransferrin''* > 0% 106 (2%) 4 (<1%) 5 (<1%) 12 (1%) 28 (5%) 23 (9%) 14 (12%) 20 (17%) < 0.001 < 0.001 
The number of participants is displayed as number (percentage of all participants). Continuons variables are expressed as mean ± standard deviation and categorical variables as number 
(percentage in the category). Total percentages do not always match 100% because of rouncling. 
*P-values using ANOVA or x2-test. 
t P-values for trend with a test of trend across ail alcohol conswnption levels after linear or logistic regression. 
tTotal weekly physical activity in min/week was calculated as the number of minutes of walking in a usual day +the amount of 20-min periods of intense activity in a usual week. 
§yGT, y-glutamyl transferase; CDT, carbohydrate-deficient transferrin (asialo- + clisialotransferrin, available in 5905 participants). 
iJBecause of its skewed distribution, yGT is displayed as geometric means with 95% confidence intervals; P-values were calculated after ln-transformation. 
**Normal CDT, combining asialo- and disialotransferrin, was defined as < 1.63 % of total transferrin, a eut-off value inclucling the 97.5th percentile of both abstainers and 'social drinkers' ( < 30 g 
ethanol/day) [18]. Normal asialotransferrin was defined as 0%, because detectable values enable to identify abusive and chronic alcohol conswnption [18]. 
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Multivariate-adjusted metabolic variables accorcling to alcohol consumption in drinks during the last 7 days 
Non-drinkers Low risk Medium to high risk Very high P for Pn-1 P1-vh Pn-vh 
0 1-6 7-13 14-20 21-27 28-34 2': 35 trend" valu et valuet valuet 
Number of participants 1670 (27%) 2181 (35%) 1202 (19%) 613 (10%) 264 (4%) 116 (2%) 126 (2%) 
Weight variables 
Body mass index (kg/m2 ) 26.6 ± 0.1 25.6 ± 0.1 25.4 ± 0.1 25.3 ± 0.2 25.7 ± 0.3 26.0 ± 0.4 25.9 ± 0.4 0.48 < 0.001 0.52 0.50 
Obesity (BMI 2': 30 kg/m2 , %) 20 (18-22) 13 (12-15) 11 (9-13) 13 (11-16) 14 (10-18) 12 (8-19) 15 (10-22) 0.36 < 0.001 0.45 0.46 
Lipid variables 
Triglycerides (mmol/l)t 1.22 ± 1.01 1.15 ± 1.01 1.15 ± 1.01 1.14 ± 1.02 1.28 ± 1.03 1.32 ± 1.05 1.37 ± 1.05 < 0.001 < 0.001 < 0.001 0.03 
HDL cholesterol (mmol/I) 1.54 ± 0.01 1.62 ± 0.01 1.68 ± 0.01 1.74 ± 0.02 1.76 ± 0.02 1.79 ± 0.04 1.87 ± 0.03 < 0.001 < 0.001 < 0.001 < 0.001 
Blood pressure variables 
Systolic (mmHg) 128.6 ± 0.4 126.7 ± 0.3 127.6 ± 0.4 131.0 ± 0.6 132.2 ± 1.0 133.4 ± 1.4 134.1±1.4 < 0.001 < 0.001 < 0.001 0.001 
Diastolic (mmHg) 79.1±0.3 78.5 ± 0.2 78.8 ± 0.3 81.1 ± 0.4 82.5 ± 0.7 83.4 ± 1.0 82.2 ± 0.9 < 0.001 0.06 < 0.001 0.008 
Glucose and insulin variables 
Fasting glucose (mmol/I) 5.58 ± 0.03 5.50 ± 0.02 5.53 ± 0.03 5.55 ± 0.05 5.62 ± 0.07 5.96 ± 0.10 5.74 ± 0.10 < 0.001 0.03 0.02 0.21 
In untreated participants§ 5.40 ± 0.02 5.41 ± 0.02 5.43 ± 0.02 5.47 ± 0.03 5.53 ± 0.05 5.60 ± 0.08 5.70 ± 0.07 < 0.001 0.42 < 0.001 0.001 
Fasting insulin (µIU/ml) 9.39 ± 0.16 8.65 ± 0.14 7.97 ± 0.19 8.46 ± 0.27 9.08 ± 0.42 8.76 ± 0.60 9.47 ± 0.59 0.50 < 0.001 0.06 0.59 
Metabolic criteria (%) 
High waist circumference'lf 34 (32-37) 26 (24-28) 26 (23-28) 24 (21-28) 31 (25-37) 35 (26-45) 38 (30-48) 0.03 < 0.001 0.004 0.35 
High triglycerides 26 (24-28) 22 (21-24) 21 (19-24) 22 (19-26) 29 (24-35) 26 (20-35) 32 (25-40) 0.02 0.005 0.01 0.07 
Low HDL cholesterol 18 (16-20) 13 (12-15) 8 (7-10) 7 (6-10) 7 (5-11) 6 (3-12) 6 (3-10) < 0.001 < 0.001 0.02 0.001 
High blood pressure 54 (51-57) 49 (46-51) 48 (44-51) 53 (48-57) 61 (54-67) 70 (59-78) 72 (62-80) < 0.001 0.001 < 0.001 0.002 
High fasting glucose 29 (26-31) 28 (26-30) 31 (28-33) 32 (29-36) 37 (31-43) 44 (35-54) 41 (32-50) < 0.001 0.82 0.01 0.007 
Number of metabolic criteria 1.6 ± <0.1 1.4 ± <0.1 1.4 ± <0.1 1.4 ± 0.1 1.7 ± 0.1 1.8 ± 0.1 1.9 ± 0.1 < 0.001 < 0.001 < 0.001 0.03 
The adjustment mode! includes age, gender, smoking status, physical activity and education level. The number of participants is displayed as number (percentage in ail participants). Continuous 
variables are expressed as mean ± standard error and categorical variables as prevalence (95% confidence interval). P-values comparing ail consumption categories were < 0.001 for ail variables, 
using ANOVA or x2-test. 
"P-values for trend with a test of trend across ail alcohol consumption levels after linear or logistic regression. 
tPn-1 values compare non-drinkers with low-risk drinkers, P1-vh low-risk with very-high-risk drinkers and Pn-vh non-drinkers with very-high-risk drinkers. 
tTriglycerides were ln-transformed because of a non-normal distribution. 
§Oral hypoglycaemic medications or insulin were not used by 5931 participants. 
ifWaist circumference was measured using a plastic tape, midway between the lowest rib and the iliac crest, with the subject standing at the end of a gentle expiration. 
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Prevalence of the metabolic syndrome or diabetes and mean homeostasis mode! assessment of insulin resistance (HO MA-IR) according to alcohol 
consumption in drinks during the last 7 days 
Medium to Very high 
Non-drinkers: Low risk: 1-13 high risk: 14-34 risk: è' 35 Pn-1 
value'· 
P1-vh 
value" 
Pn~vh 
value'· 0 drink/week drinks/week drinks/week drinks/week 
Number of participants 1670 (27%) 3383 (55%) 993 (16%) 126 (2%) 
Metabolic syndrome (%) 
Unadjusted 24 (22-26) 21 (20-22) 28 (25-31) 40 (32-49) 0.008 < 0.001 < 0.001 
Adjusted 24 (22-27) 19 (18-20) 20 (18-23) 29 (22-38) < 0.001 0.005 0.17 
Diabetes (%) 
Unadjusted 6.9 (5.8-8.2) 5.3 (4.6-6.1) 8.3 (6.7-10.1) 15.l (9.8-22.4) 0.02 < 0.001 0.001 
Adjusted 6.0 (4.9-7.3) 3.6 (3.0-4.3) 3.8 (2.9-4.9) 6.7 (4.1-10.9) < 0.001 0.046 0.40 
HO MA-IR 
Unadjusted 2.36 ± 0.06 2.14 ± 0.04 2.52 ± 0.08 2.87 ± 0.21 0.002 < 0.001 0.08 
Adjusted 2.47 ± 0.06 2.14 ± 0.04 2.27 ± 0.08 2.53 ± 0.21 < 0.001 0.04 0.59 
The number of participants is displayed as number (percentage of al! participants). The metabolic syndrome and diabetes are expressed as 
prevalence (95% confidence interval) and HOMA-IR as mean ± standard error. The adjustment mode! includes age, gender, smoking status, 
physical activity and education level. P-values comparing al! consumption categories were < 0.001 for al! variables, using x2-test or ANOVA. 
"P n-1 values compare non-drinkers with low-risk drinkers, P1-vh low-risk with very-high-risk drinkers and Pn-vh non-drinkers with very-high-
risk drinkers. 
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Alcohol consuption în drinks duringthe last 7 days 
Adjusted prevalence of the metabolic syndrome or diabetes and 
mean homeostasis mode! assessment of insulin resistance (HOMA-IR) 
according to alcohol consumption in drinks during the last 7 days. The 
adjustmentmodel includes age, gender, smoking status, physical activityand 
education level. The adjusted prevalence of the metabolic syndrome, 
diabetes and HOlvlA-IR was significantly reduced in drinkers of 1-13 
drinks/week compared with 0 drink/week (al! P < 0.001) and to 
è' 35 drinks/week (al! P < 0.05), but none was significantly increased in 
drinkers of è' 35 drinks/week compared with 0 drink/week. 
non-drinkers (18%) and higher than among low-risk drinkers 
(13 % ). Trends across alcohol consumption levels for drinkers of 
~ 7 drinks/week were all significant (all P s; 0.003). Excluding 
self-reported Type 1 diabetes from the definition of diabetes did 
not alter the results (data not shown). Adjusting models of 
diabetes and HOMA-IR for BMI, waist circumference, waist-
hip ratio or history of diabetes in first-degree relatives or 
removing diagnoses based on glucose levels only did not change 
the shape of these relationships (data not shown). 
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Beverage types 
The adjusted regression coefficients of wine, beer and spirits were 
not significantly different for the metabolic syndrome (P = 0.73 ), 
diabetes (P = 0.90) and HOMA-IR (P = 0.65), after adjustment 
for age, gender, smoking status, physical activity, education level 
and the number of drinks for each beverage type (see also 
Supporting Information, Table 52). 
In this population-based study including a substantial proportion 
of high-risk drinkers, we found U-shaped relationships between 
alcohol use and the prevalence of the metabolic syndrome 
and diabetes, with reduced prevalence in low-risk drinkers 
and increased prevalence in very-high-risk drinkers. These 
relationships did not differ according to beverage types. Our 
results support the hypothesis of a protective effect of low-risk 
alcohol consumption on the metabolic syndrome and diabetes, 
which disappears at higher drinking levels. 
For the metabolic syndrome, previous studies have found 
conflicting results on its relationship with alcohol, using varions 
definitions of alcohol consumption [2-6] and including few high-
risk drinkers [7]. High-risk drinkers were often included in the 
low-risk consumption category, attributable to insufficient 
numbers. For example, analyses of the US National Health and 
Nutrition Examination Survey (NHANES) have defined the 
highest consumption category as~ 20 drinks in the last month [2] 
-or either ~ 1 drink/day in the last month or~ 5 drinks/day ever 
[3]. In the Korean NHANES [4], which included drinkers up to 
~ 80 g/day, the odds ratio of the metabolic syndrome increased 
across drinking categories (P < 0.005). However, this study was 
restricted to Asian adults and did not confirm alcohol 
© 201 0 The Authors. 
Diabetic Medicine © 2010 Diabetes UK 
Original article 
consumption with laboratory tests. In a Greek study, mild-to-
moderate drinkers had a reduced odds ratio of the metabolic 
syndrome and the opposite for heavy drinkers, defined as 
> 45 g!dayor> 60 gatonesitting [6]. However, the adjustment 
mode! only included age, gender and smoking and regular heavy 
drinkers were mixed with occasional binge drinkers, again 
without biochemical confirmation. A recent meta-analysis found 
significantly reduced odds ratios of the metabolic syndrome in 
men drinking 0-39.9 g/day and women drinking 0-19.9 g/day 
[7]. No significant relationship was found at higher drinking 
levels, but the authors mentioned that their meta-analysis 
included few high-risk drinkers, potentially leading to 
underpowered inference about the effect of harmful drinking 
on the metabolic syndrome. They also found no data in women 
drinking > 40 g/day. Regarding differences between beverage 
types, previous studies have shown conflicting results, using 
various statistical methods [2,5,12]. Such differences might be 
attributed to residual confounding because of differences in 
lifestyle factors, such as being better educated or an ex-smoker 
[12]. 
Regarding the association between alcohol and diabetes, our 
results are in agreement with previous meta-analyses [13,14]. In 
moderate drinkers, defined as~ 48 g/day (~4 drinks/day) [13] 
or ~ 30 g/day (~3 drinks/day) [14], the risk of diabetes was 
reduced by ~30% compared with non-drinkers. Similar to our 
study, Koppes et al. [13] have found an increased, albeit non-
significant, risk of diabetes in drinkers of> 48 g/day compared 
with non-drinkers. However, few subjects were included in this 
category. Beverage types were rarely compared, with conflicting 
results [13]. As mentioned above for the metabolic syndrome, 
residual confounding for differences in lifestyle factors cannot be 
excluded [13]. 
The U-shaped relationships between alcohol consumption, 
metabolic syndrome and diabetes might be explained by the 
complex interaction of alcohol consumption with metabolic 
factors. Most of the previous epidemiological studies have 
shown a reduced insulin resistance in low-risk drinkers, but few 
and conflicting data exist about high-risk alcohol consumption 
[15]. In adjusted analyses, we found that insulin resistance also 
followed a U-shaped relationship with alcohol use and higher 
insulin resistance is associated with high-risk drinking. This may 
contribute to the U-shaped relationships of alcohol with the 
metabolic syndrome and diabetes, because insulin resistance is a 
central element in both conditions. Sinùlar to our results, a 
favourable metabolic profile has been reported in low-risk 
drinkers, with significantly reduced obesity, triglycerides, blood 
pressure and increased HDL cholesterol [2,10,11]. However, 
high-risk drinking has been associated with increased blood 
pressure [8] and triglycerides [9], but also higher HDL 
cholesterol [10]. This balance between risk and protective 
factors among very-high-risk drinkers may explain the similar 
prevalence of the metabolic syndrome or diabetes in very-high-
risk drinkers compared with non-drinkers. The biologie 
mechanisms by which chronic alcohol consumption affects 
metabolic factors are only partially understood. Complex effects 
© 201 O The Authors. 
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on glucose metabolism, lipoproteins, particularly HDL fonction 
and LDL oxidation, insulin secretion, energy balance, 
inflammation mediators, stress and sex hormones, vascular 
walls and the sympathetic nervous system have been suggested 
[9,15,27]. 
This study has several limitations. First, alcohol consumption 
was self reported. It might lead to a selective misclassification of 
high-risk drinkers as low-risk drinkers because of under-
reporting, which would decrease any potential association. 
However, most epidemiological studies on alcohol consumption 
have relied on self-reported data and we used blood levels of 
y-glutamyl transferase and carbohydrate-deficient transferrin as 
an objective confirmation of the self-reported alcohol use. To 
our knowledge, such a confirmation was rarely carried out 
in our tapie with y-glutamyl transferase [12] and never 
with carbohydrate-deficient transferrin. Furthermore, 1-week 
consumption reports are more accurate for the assessment of 
high-risk drinking than quantity-frequency measures [28] and 
are highly correlated with daily reports [28] or food-frequency 
questionnaires [29]. A recall period limited to 1 week may 
misclassify some participants usually drinking alcohol, but 
abstaining during this week or others drinking more in 
this week than usual. There is no general consensus for the 
definition of low-risk drinking [3,7,20]. We selected the upper 
limit of 14 drinks/week, based on US and Australian guidelines 
[21,22]. Our study neither captured drinking patterns, such as 
binge drinking, nor specific food parameters affecting metabolic 
variables, which might lead to residual confounding. Sorne 
previous studies that adjusted for food intake also found a 
reduced prevalence of the metabolic syndrome in low-risk 
drinkers [2,5]. The relatively low proportion of beer and 
spirit use limited the comparison of beverage types. The 
definition of diabetes was based on a single laboratory 
measurement, similar to most previous cross-sectional 
studies [5,6]. Finally, the cross-sectional nature of our data 
does not allow any definitive causal inference, but very few 
prospective studies on the association between alcohol 
consumption and the metabolic syndrome exist, particularly 
with sufficient number of high-risk drinkers [7]. Our study 
also has important strengths, such as the large, population-based 
sample with both genders, the high mean alcohol 
consumption and the objective confirmation of alcohol 
consumption by y-glutamyl transferase and carbohydrate-
deficient transferrin. 
In conclusion, our findings indicate that alcohol has a 
U-shaped relationship with the metabolic syndrome, diabetes 
and HOMA-IR, without differences between beverage types. In 
future research, prospective data should confirm the relationship 
of alcohol consumption with the metabolic syndrome and 
-diabetes, particularly for high-risk drinkers, as well as the impact 
of binge drinking. Future studies might also better quantify 
alcohol consumption, for example with 12-month assessments 
and more detailed questions [30]. Finally, the potential 
interactions of these relationships with other factors, such as 
genes, should be investigated. 
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Additional Supporting Information may be found in the online 
version of this article: 
Table Sl. Unadjusted metabolic variables according to alcohol 
consumption in drinks during the last 7 days. 
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Table S2. Adjusted regression coefficients of beverage types for 
the metabolic syndrome, diabetes and HOMA-IR in drinkers of 
at least 7 drinks in the last 7 days. 
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